Thimerosal - Adverse effects
Research News and Information

Sunday, November 22, 2009

Autism and vaccination-the current evidence.

29 Jun 2009 PURPOSE: The purpose of this article is to review relevant background literature regarding the evidence linking thimerosal-containing vaccine and the measles, mumps, and rubella vaccine to autism. CONCLUSIONS: Rigorous scientific studies have not ... Read more...

Cutaneous allergy testing in patients suspected of an allergic reaction to eye medication.

13 May 2009 PURPOSE: Our aim was to determine the usefulness of allergy testing in patients with possible allergic reactions to an eye medication. METHODS: This retrospective study analyzed the usefulness of allergy testing in 90 patients who on the basis of ... Read more...

Neonate exposure to thimerosal mercury from hepatitis B vaccines.

10 Mar 2009 Infant exposure to ethylmercury (EtHg) has not only increased but is starting earlier as a result of the current immunization schedule that uses thimerosal-containing vaccines (TCVs). Although vaccination schedule varies considerably between ... Read more...

Latest indexed articles for 'Thimerosal - Adverse effects'

These are the very latest articles for this heading:

• Autism and vaccination-the current evidence. 29 Jun 2009
• Litigation, regulation, and education--protecting the public's health through childhood immunization. 9 Jun 2009
• When vaccine injury claims go to court. 9 Jun 2009
• Breast-feeding does a lot more than reduce pain in vaccinated neonates and infants. 30 May 2009
• Cutaneous allergy testing in patients suspected of an allergic reaction to eye medication. 13 May 2009
• Re: "Determinants of the incidence of childhood asthma: a two-stage case-control study". 9 May 2009
• Neonate exposure to thimerosal mercury from hepatitis B vaccines. 10 Mar 2009
• The rise in autism and the mercury myth. 30 Jan 2009
• Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines. 30 Jan 2009
• Presence of thimerosal in vaccines. 22 Jan 2009
• Thimerosal-containing vaccines: evidence versus public apprehension. 30 Dec 2008
• Autism spectrum disorders: prevalence and vaccines. 30 Dec 2008
• Autism overflows: increasing prevalence and proliferating theories. 16 Nov 2008
• Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. 29 Sep 2008
• Thimerosal and the relevance of patch-test reactions in children. 30 Aug 2008
• Meeting of Global Advisory Committee on Vaccine Safety, 18-19 June 2008. 6 Aug 2008
• Update on autism and childhood vaccines. 30 Jul 2008
• National vaccine injury compensation program: the potential impact of Cedillo for vaccine-related autism cases. 29 Jun 2008
• Mercury, vaccines, and autism, revisited. 10 Jun 2008
• Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. 13 May 2008

See a longer list of these articles.

Technical information about 'Thimerosal'

Definition: An ethylmercury-sulfidobenzoate that has been used as a preservative in VACCINES; ANTIVENINS; and OINTMENTS. It was formerly used as a topical antiseptic. It degrades to ethylmercury and thiosalicylate.

Chemical name: Mercurate(1-), ethyl(2-mercaptobenzoato(2-)-O,S)-, sodium

Registry Number: 54-64-8

Descriptor UI: D013849

Alternative terms: Thimerosal; Sodium Ethylmercurithiosalicylate; Ethylmercurithiosalicylate, Sodium; Thiomersalate; Mercurothiolate; Thiomersal; Vitaseptol; Novartis Brand of Thimerosal; Merthiolate;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Pharmacological Action: Preservatives, Pharmaceutical;

Tree Number: D02.691.750.100.347.850;

History Note: 91(75); was see under ETHYLMERCURY COMPOUNDS 1980-90; was see under ETHYL MERCURY COMPOUNDS 1975-79